{"nctId":"NCT01462812","briefTitle":"Safety & Efficacy of a Single Dose of Sumatriptan Powder Delivered Intranasally With the Bi-directional Device in Adults With Acute Migraine","startDateStruct":{"date":"2011-01"},"conditions":["Migraine Headache"],"count":223,"armGroups":[{"label":"Sumatriptan","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Sumatriptan"]},{"label":"Matching placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Sumatriptan","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Men or women, between the ages of 18 to 65 years\n* Diagnosis of migraine, with or without aura\n* Experiences between 1 and 8 migraine attacks per month for the past 12 months\n\nExclusion Criteria:\n\n* Inability to distinguish other headaches from migraine\n* Experiences headache of any kind at a frequency greater than or equal to 15 days per month\n* History of resistance to sumatriptan, or non-response to 2 or more other triptans, defined as subjects who have not responded to an adequate dose and duration of treatment\n* Current use of medication for migraine prophylaxis that has not been stable (no dose adjustment) for 30 days prior to screening\n* Chronic opioid therapy (\\>3 consecutive days in the 30 days prior to screening)","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Headache Relief","description":"The primary objective for this study is to compare headache relief (defined as a reduction from moderate \\[Grade 2\\] or severe \\[Grade 3\\] pain to none \\[Grade 0\\] or mild \\[Grade 1\\] pain) at 120 minutes following a dose of 20 mg of OPTINOSE SUMATRIPTAN with placebo in the acute treatment of a single migraine attack.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"47","spread":null},{"groupId":"OG001","value":"73","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":111},"commonTop":["Product Taste Abnormal","Nasal Discomfort","Rhinorrhoea","Rhinitis"]}}}